WHITE PAPER: Creating Effective Pharmaceutical Marketing PART 1

Drive Education, Adherence and Growth Through Behavioral Science
WHITE PAPER: Creating Effective Pharmaceutical Marketing PART 1
Pharmaceutical marketing is evolving. Patients, caregivers, and healthcare providers make decisions based on more than just logic, they are influenced by behavioral patterns, biases, and personal experiences. This three-part white paper series explores how behavioral science can transform pharmaceutical marketing, improving patient engagement, adherence, and commercial success.

Explore how leading pharmaceutical brands are applying behavioral science to build stronger connections, improve patient adherence, and maximize impact.

 

What You’ll Learn in Part 1:

  • How behavioral science reveals what patients will actually do, not just what they say they’ll do
  • The role of choice architecture in guiding patient and healthcare provider decisions
  • The impact of custom behavioral research in driving effective, personalized marketing strategies

 

For years, marketers have relied on traditional approaches and secondary research. But formulaic strategies fail to capture the real patient experience. Primary behavioral research combined with decision-science frameworks offers a more effective way to engage patients and influence behavior at key moments in their journey.

Upcoming Releases:

 

Part 3 (Mid-April) – Real-world applications and case studies in pharma marketing

Let’s co-create the next win,
fueled by shared learning.